EUCTR2005-000823-40-IT进行中（未招募）不适用
Double-blind placebo COntrolled dose Ranging studYof the eFficacy and safEty of SSR149744C 300 or 600 mg for the conversion of atrial fibrillation/fluttEr CORYFEE
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 141
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
1 期
Placebo controlled double blind dose ranging study of the efficacy and safety of SSR149744C 50, 100, 200, or 300 mg OD, with amiodarone as calibrator for the maintenance of sinus rhythm in patients with recent atrial fibrillation/flutter.Atrial fibrillation/flutterMedDRA version: 7.0Level: PTClassification code 10003658EUCTR2004-001766-40-ESSanofi-Synthelabo Recherche660
进行中（未招募）
不适用
Placebo controlled double blind dose ranging study of the efficacy and safety of SSR149744C 50, 100, 200 or 300 mg OD, with amiodarone as calibrator for the maintenance of sinus rhythm in patients with recent atrial fibrillation/flutterEUCTR2004-001766-40-ITSANOFI-SYNTHELABO
进行中（未招募）
不适用
Placebo controlled double blind dose ranging study of the efficacy and safety of SSR149744C 50, 100, 200, or 300 mg OD, with amiodarone as calibrator for the maintenance of sinus rhythm in patients with recent atrial fibrillation/flutter. - MAIAAtrial fibrillation/flutterMedDRA version: 7.0Level: PTClassification code 10003658EUCTR2004-001766-40-DKSanofi-Synthelabo Recherche660
进行中（未招募）
不适用
Placebo controlled double blind dose ranging study of the efficacy and safety of SSR149744C 50, 100, 200, or 300 mg OD, with amiodarone as calibrator for the maintenance of sinus rhythm in patients with recent atrial fibrillation/flutter. - MAIAAtrial fibrillation/flutterMedDRA version: 7.0Level: PTClassification code 10003658EUCTR2004-001766-40-SESanofi-Synthelabo Recherche660
进行中（未招募）
不适用
Placebo controlled double blind dose ranging study of the efficacy and safety of SSR149744C 50, 100, 200, or 300 mg OD, with amiodarone as calibrator for the maintenance of sinus rhythm in patients with recent atrial fibrillation/flutter.Atrial fibrillation/flutterMedDRA version: 7.0Level: PTClassification code 10003658EUCTR2004-001766-40-DESanofi-Synthelabo Recherche660